.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Medtronic
QuintilesIMS
Covington
Julphar
Mallinckrodt
Citi
Boehringer Ingelheim
Federal Trade Commission
Express Scripts

Generated: June 27, 2017

DrugPatentWatch Database Preview

Carboplatin - Generic Drug Details

« Back to Dashboard

What are the generic sources for carboplatin and what is the scope of carboplatin freedom to operate?

Carboplatin
is the generic ingredient in two branded drugs marketed by Pliva, Mylan Labs Ltd, Hospira, Gland Pharma Ltd, Sun Pharma Global, Pliva Lachema, Actavis Totowa, Fresenius Kabi Oncol, Fresenius Kabi Usa, Teva Pharms Usa, West-ward Pharms Int, Cordenpharma, Sandoz, Cipla Ltd, Watson Labs Teva, Akorn, Pharmachemie Bv, Accord Hlthcare, Corden Pharma, Sandoz Inc, Ingenus Pharms Llc, Sanja Pharms Co, Teva Parenteral, Nanjing King-friend, and Mylan Institutional, and is included in thirty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Eleven suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: carboplatin

Tradenames:2
Patents:1
Applicants:25
NDAs:35
Drug Master File Entries: see list18
Suppliers / Packagers: see list11
Bulk Api Vendors: see list73
Clinical Trials: see list1,876
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:carboplatin at DailyMed

Pharmacology for Ingredient: carboplatin

Tentative approvals for CARBOPLATIN

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe50MG/VIALINJECTABLE;INJECTION
► Subscribe► Subscribe450MG/VIALINJECTABLE;INJECTION
► Subscribe► Subscribe150MG/VIALINJECTABLE;INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva
CARBOPLATIN
carboplatin
INJECTABLE;INJECTION076602-002Nov 16, 2004DISCNNoNo► Subscribe► Subscribe
Sanja Pharms Co
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)205487-003Mar 28, 2016APRXNoNo► Subscribe► Subscribe
Pharmachemie Bv
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077679-003Feb 25, 2009DISCNNoNo► Subscribe► Subscribe
Corden Pharma
PARAPLATIN
carboplatin
INJECTABLE;INJECTION019880-003Mar 3, 1989DISCNYesNo► Subscribe► Subscribe
Teva Pharms Usa
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077139-004Sep 21, 2005APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cordenpharma
PARAPLATIN
carboplatin
INJECTABLE;IV (INFUSION)020452-004Jan 15, 20044,657,927*PED► Subscribe
Corden Pharma
PARAPLATIN
carboplatin
INJECTABLE;INJECTION019880-002Mar 3, 19894,657,927*PED► Subscribe
Cordenpharma
PARAPLATIN
carboplatin
INJECTABLE;IV (INFUSION)020452-001Jul 14, 20034,657,927*PED► Subscribe
Cordenpharma
PARAPLATIN
carboplatin
INJECTABLE;IV (INFUSION)020452-003Jul 14, 20034,657,927*PED► Subscribe
Corden Pharma
PARAPLATIN
carboplatin
INJECTABLE;INJECTION019880-003Mar 3, 19894,657,927*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Accenture
Covington
UBS
Harvard Business School
Baxter
Queensland Health
Julphar
Chubb
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot